Buprenorphine tablets

Description

Buprenorphine tablets

If you have also wondered what buprenorphine is? What are its uses, contraindications, drug interactions, and side effects? Stay with us until the end of this article. Buprenorphine sublingual tablet is a semi-synthetic opioid derived from thebaine. This pharmaceutical product is a partial agonist of the µ receptor and a Κ receptor antagonist.

Buprenorphine sublingual tablets are produced by Kish Medipharm Pharmaceutical Company in packs of 100 and doses of 2 mg, 0.4 mg, and 8 mg. This product can be purchased at pharmacies with a prescription from a specialist. Considering that buprenorphine tablets are generic, they are cheap and affordable.

Buprenorphine tablets are available in sublingual and routine forms worldwide. Sublingual buprenorphine tablets must be placed completely under the tongue for best absorption.

Side effects of buprenorphine tablets

All pharmaceutical products are manufactured to treat physical and mental illnesses and problems, but it should be noted that they may not be suitable for all people. Side effects of buprenorphine can occur due to drug interactions. Other factors that can cause these unwanted problems are: age, gender, physical health conditions, taking more or less than recommended by a doctor, medical history, smoking and alcohol use. Below are the side effects of buprenorphine tablets:

• Itching
• Urinary retention
• Vision problems
• Dizziness and headache
• Stress and anxiety
• Nausea and vomiting
• Severe drop in blood pressure
• Excessive fatigue and boredom
• Feeling of extreme happiness and joy
• Increased intracranial pressure and respiratory depression (must be taken seriously)

Buprenorphine tablets for premature ejaculation

As mentioned, sublingual buprenorphine is considered an effective drug for addiction treatment. Some people use this drug as a solution for delayed ejaculation. Although research has shown that some opioid medications have an effect on ejaculation, there is still no complete evidence that buprenorphine is effective for premature ejaculation and its positive effects.

Since buprenorphine affects the levels of neurotransmitters in the brain (serotonin, norepinephrine, and dopamine), it may indirectly affect delayed ejaculation. In general, buprenorphine is not for premature ejaculation, although it may lead to more time for sexual intercourse in some people. Also, experts do not consider sublingual buprenorphine to be a delay product. If you have decreased libido or premature ejaculation, you can consult a specialist to use other alternatives.

 Uses and benefits of buprenorphine tablets

The benefits of buprenorphine tablets and its uses have made it one of the first choices among specialists. The benefits of buprenorphine tablets include the following:

• Reducing drug withdrawal symptoms
• Very powerful reliever for chronic pain
• Preventing substance abuse relapse in people with a history of abuse
• Drug addiction treatment for detoxification and also as maintenance treatment
• Helping to quit addiction to opiates and narcotics such as morphine, codeine, and heroin

Contraindications for buprenorphine tablets

Although sublingual buprenorphine tablets have many benefits, they are not beneficial for everyone and can cause drug interactions, resulting in unwanted side effects and irreversible problems. Other contraindications for buprenorphine tablets include the following:

• Having an allergy to buprenorphine tablets or any inactive ingredients in this product
• Elderly people, especially those over 65 years of age
• Severe and acute renal, pulmonary, and hepatic failure
• Irregular thyroid gland functions
• Suffering from prostatic hyperplasia
• People addicted to narcotics
• Pregnant and breastfeeding women
• Physically disabled people
• Children under 6 years old
• Nervous depression
• Adrenal insufficiency
• Acute alexism
• Urethral obstruction
• Coma

Maintenance treatment with sublingual buprenorphine tablets

Maintenance treatment with buprenorphine tablets consists of 3 stages: induction, stabilization, and maintenance. Below we will discuss each of the 3 stages in detail:

• First day of treatment: Before starting induction, patients using short-acting opioids such as heroin, opium, and morphine should have at least 4 to 24 hours since their last use. In the case of methadone, this time period changes and is considered between 24 and 48 hours. After the appearance of mild to moderate withdrawal symptoms, the first dose of buprenorphine tablets, which is usually between 2 and 4 mg, is given to the patient and the patient should be monitored for 2 hours. When withdrawal symptoms resume, the second dose is given to the patient and it is important to note that the dose of buprenorphine sublingual tablets on the first day should not exceed 8 mg.
• Day 2 of treatment: Specialists evaluate the patient's response to the buprenorphine sublingual tablet on the first day. If withdrawal symptoms disappear, the first day's dose is considered the total dose. Otherwise, in addition to the first day's dose, 4 mg of buprenorphine tablets will be added to the dose of the drug. If withdrawal symptoms occur after 2 hours, the next dose of the drug, which is 2 to 3 mg, will be given to the patient. The dose of buprenorphine tablets on the second day should not exceed 16 mg per day.
• The dose increase for induction therapy is considered to be 8 mg daily, up to a maximum of 32 mg per day. If withdrawal symptoms are not controlled and eliminated with the aforementioned daily doses, symptom relief with non-narcotic pharmacological interventions under the supervision of specialists is recommended. If the final dose of buprenorphine sublingual tablet causes a feeling of euphoria in the patient, 2 mg should be reduced from the starting dose.
• Induction phase: Treatment is aimed at helping the patient to replace the abused drug with sublingual buprenorphine.

Conclusion

If you have ever found out what buprenorphine tablets are, you know that this drug can only be purchased with a doctor's prescription and that a person cannot receive this drug without a prescription. Buprenorphine sublingual tablets are produced in doses of 2 mg, 0.4 mg and 8 mg by Kish Medipharm Pharmaceutical Company. The benefits of buprenorphine tablets make this drug treat chronic pain, reduce withdrawal symptoms and help with morphine and codeine addiction. Buprenorphine tablets are not intended for premature ejaculation.

Buprenorphine tablets are available to consumers only by prescription, and there are certainly important points about their use. We have tried to introduce the sublingual buprenorphine tablet here, but all of this is just for your information about the product in question, and you should be under the full supervision of a medical professional during the course.